Analystreport

Atara Biotherapeutics (NASDAQ: ATRA) is now covered by analysts at JPMorgan Chase. They set an "overweight" rating on the stock.

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations